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Background: Mutations leading to changes in properties, regulation, or expression of
connexin-made channels have been implicated in 28 distinct human hereditary diseases.
Eight of these result from variants of connexin 26 (Cx26), a protein critically involved
in cell-cell signaling in the inner ear and skin. Lack of non-toxic drugs with defined
mechanisms of action poses a serious obstacle to therapeutic interventions for diseases
caused by mutant connexins. In particular, molecules that specifically modulate connexin
hemichannel function without affecting gap junction channels are considered of primary
importance for the study of connexin hemichannel role in physiological as well as
pathological conditions. Monoclonal antibodies developed in the last three decades
have become the most important class of therapeutic biologicals. Recombinant methods
permit rapid selection and improvement of monoclonal antibodies from libraries with large
diversity.
Methods: By screening a combinatorial library of human single-chain fragment variable
(scFv) antibodies expressed in phage, we identified a candidate that binds an extracellular
epitope of Cx26. We characterized antibody action using a variety of biochemical and
biophysical assays in HeLa cells, organotypic cultures of mouse cochlea and human
keratinocyte-derived cells.
Results: We determined that the antibody is a remarkably efficient, non-toxic, and
completely reversible inhibitor of hemichannels formed by connexin 26 and does not
affect direct cell-cell communication via gap junction channels. Importantly, we also
demonstrate that the antibody efficiently inhibits hyperative mutant Cx26 hemichannels
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implicated in autosomal dominant non-syndromic hearing impairment accompanied
by keratitis and hystrix-like ichthyosis-deafness (KID/HID) syndrome. We solved the
crystal structure of the antibody, identified residues that are critical for binding and used
molecular dynamics to uncover its mechanism of action.
Conclusions: Although further studies will be necessary to validate the effect of the
antibody in vivo, the methodology described here can be extended to select antibodies
against hemichannels composed by other connexin isoforms and, consequently, to
target other pathologies associated with hyperactive hemichannels. Our study highlights
the potential of this approach and identifies connexins as therapeutic targets addressable
by screening phage display libraries expressing human randomized antibodies.
Keywords: syndromic autosomal hereditary deafness, cochlea, keratinocytes, connexins, antibody library,
antibody structure, epitope identification
INTRODUCTION
Connexin-made channels are essential and widespread
constituents of the cell-cell communication pathways that
enable the direct exchange of nutrients and signaling molecules
between adjacent cells (Goodenough and Paul, 2009) or between
cell cytoplasm and the extracellular milieu (Saez and Leybaert,
2014). Channel constituents are structurally homogeneous
plasma membrane proteins encoded by twenty one connexin
genes in the human genome (http://www.genenames.org/cgi-
bin/genefamilies/set/314). Connexin proteins share the same
topology that comprises four transmembrane domains (TM1–
TM4) connected by two extracellular loops (EC1 and EC2) and a
cytoplasmic loop (CL), while the N- and C-termini (NT, CT) of
the protein extend into the cytoplasm of the cell (Maeda et al.,
2009). Connexins are post-translationally oligomerized to form
hexameric assemblies, known as connexons or hemichannels,
prior to membrane insertion either within the endoplasmic
reticulum or in the trans-Golgi network (Esseltine and Laird,
2016). Connexin hemichannels are then trafficked to the
plasma membrane, where the head-to-head docking of two
hemichannels from adjacent cells promotes the formation of
an intercellular (gap junction) channel. These channels are
characterized by an aqueous pore with a diameter typically
>1 nm (Maeda et al., 2009; Esseltine and Laird, 2016; Zong et al.,
2016), and are permeable to several current-carrying anions and
cations and low molecular weight molecules, including glycolytic
intermediates, vitamins, amino acids, nucleotides, as well as
some of the more important second messengers involved in cell
signaling (Niessen et al., 2000; Beltramello et al., 2005; Bedner
et al., 2006; Hernandez et al., 2007; Kanaporis et al., 2008).
Unpaired connexin hemichannels in the cell plasma
membrane are kept in a predominantly closed state by at least
one of the following mechanisms (Saez et al., 2005; Fasciani
et al., 2013; Saez and Leybaert, 2014): (a) pore occlusion
by mM levels of extracellular Ca2+ and Mg2+; (b) negative
membrane potential; (c) post-translational modifications (e.g.,
phosphorylation). Open hemichannels lack ion selectivity
and mediate autocrine/paracrine signaling by the release or
uptake of small molecules including ATP, amino acids, reduced
glutathione, NAD+, prostaglandin E2, and cyclic nucleotides,
which are critical for cell-cell communication and the regulation
of inflammatory responses (Saez and Leybaert, 2014).
Mutations leading to changes in properties, regulation or
expression of connexin-made channels have been implicated in
28 distinct human hereditary diseases (Srinivas et al., 2017). Eight
of these, including KID/HID syndrome, result from GJB2 gene
variants. Four diseases, including clouston syndrome or hidrotic
ectodermal dysplasia (HED), have been linked to variants of
GJB6, a gene located just 30 kb telomeric toGJB2 on chromosome
13. These two genes encode respectively human connexin 26
(Cx26, where 26 indicated the molecular weight of the protein in
kDa) and connexin 30 (Cx30), two structurally and functionally
related gap junction proteins expressed in skin and inner ear
(Forge et al., 2003; Zhao and Yu, 2006). Epidermal disorders
associated with pathological variants of Cx26 or Cx30, for which
there is no cure, can be highly incapacitating or disfiguring, and
in some cases even fatal (Martin and van Steensel, 2015).
Mouse models for Cx26 and Cx30 mutants displayed auditory
(Leibovici et al., 2008; Wingard and Zhao, 2015) and skin
phenotypes of variable severity (Mese et al., 2011; Schutz et al.,
2011; Bosen et al., 2014, 2015; Garcia et al., 2016). Of the thirteen
dominant Cx26 mutations responsible for KID/HID syndrome
(G11E, G12R, N14K, N14Y, S17F, I30N, A40V, G45E, D50A,
D50N, D50Y, A88V) at least eight are thought to translate into
hyperactive or “leaky” hemichannels (G11E, G12R, N14K, N14Y,
A40V, G45E, D50A, D50N, A88V) (Retamal et al., 2015) that do
not close correctly in response to extracellular Ca2+ or show an
altered permeability to this critically important cation and second
messenger (Stong et al., 2006; Gerido et al., 2007; Lee and White,
2009; Mhaske et al., 2013; Garcia et al., 2015) compromising cell
viability in vitro (Stong et al., 2006; Lee and White, 2009). Of
note, mice with ectopic expression of wild type Cx26 from the
epidermis-specific involucrin promoter demonstrated increased
ATP release in keratinocytes, which delayed epidermal barrier
recovery and promoted a psoriasiform response (Djalilian et al.,
2006). Therefore, it has been proposed that increased ATP levels
act as a paracrine messenger and, by altering epidermal factors
that control the proliferation and differentiation of keratinocytes,
play a critical role in the etiology of skin conditions (Essenfelder
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et al., 2004; Garcia et al., 2016). Lack of non-toxic inhibitors
with defined mechanisms of action poses a serious obstacle
to therapeutic interventions for diseases caused by aberrant
connexin hemichannels (Saez and Leybaert, 2014; Bruzzone,
2015).
Antibodies have become a key tool in drug discovery. Their
ability to bind an antigen with a high degree of affinity and
specificity is leading them to become the largest and fastest
growing class of therapeutic proteins (Frenzel et al., 2016). Here,
we report the identification of a human recombinant antibody
that perturbs hemichannel function. For antibody discovery, we
screened a single-chain fragment variable (scFv) combinatorial
antibody library expressed in phage (Zhang et al., 2012). Each
scFv of human immunoglobulins is formed by a heavy chain
variable domain, VH, connected by a linker to a light chain
variable domain, VL (Lerner, 2016). The advantage of a synthetic
phage library (McCafferty et al., 1990; Barbas et al., 1991; Breitling
et al., 1991; Burton et al., 1991; Clackson et al., 1991) is that it
enables full control over the in vitro selection process, allows to
obtain highly functional binders rapidly and at lower cost, does
not rely on adjuvants which can unfold proteins, andmay contain
over 40 billion highly stable human antibody clones (Weber et al.,
2014). The antibody we selected is not toxic to cells, reversibly
inhibits hemichannel currents and strongly reduces the activity
of some Cx26 hyperactive mutants.
MATERIALS AND METHODS
Statistical Analysis
Data are given as mean ± standard error of the mean (s.e.m.).
Comparisons between two or more groups were conducted
by using two-tailed analysis of variance (ANOVA) or paired
t-test, as indicated in the figure legends. The Mann–Whitney
U-test was used for data which were not normally distributed
and/or had dissimilar variance. P-values are indicated by letter
P, where P < 0.05 was selected as the criterion for statistical
significance. No statistical methods were used to predetermine
sample size. The experiments were not randomized and the
investigators were not blinded to allocation during experiments
and outcome assessment. No pre-established criteria were used
to include/exclude samples or animals.
Cell Lines
All cell lines were routinely checked for mycoplasma
contamination using the Venor R© GeM Classic kit (Minerva
Biolobs, Cat. No. 11-1025).
The FreeStyleTM 293-F cell line (ThermoFisher, Cat. No.
R79007) was maintained in Freestyle 293 Expression Medium
(ThermoFisher, Cat. No. 12338026). The XL1-Blue cell line
(Agilent, Cat. No. 200228) was maintained in SB medium
composed of 32 g/L tryptone (Oxoid, Cat. No. LP0042), 20
g/L yeast extract (Oxoid, Cat. No. LP0021), 5 g/L sodium
chloride (Shanghai Sangon Biotech, Cat. No. ST1218—1 kg),
and 20µg/ml tetracycline (ShanghaiSangon Biotech, Cat. No.
BS731—10ml), pH 7.5. The culture was shaken at 37◦C until an
optical density (OD) of 0.5–0.7 was obtained at 600 nm.
HeLa DH cells (Sigma-Aldrich, Cat. No. 96112022) or HaCaT
cells (Cell Lines Service GmbH, Cat. No. 300493) were seeded
onto round glass coverslips (Fisher Scientific, Cat. No. FIS#12-
542A) at different degrees of confluence, depending on the
type of assay. Cells were maintained in Dulbecco’s modified
Eagle’s medium (ThermoFisher, Cat.No. 41965039) containing
10% (v/v) FBS (Gibco-Invitrogen, Cat.No. 10270-106) and 1%
penicillin/streptomycin (Gibco-Invitrogen, Cat.No. 15070-063).
Twenty four hours after plating, a lipofectamine transfection
reagent (Lipofectamine 2000, Cat. No. 11668-019) was used to
transiently transfect HeLa DH or HaCaT cells with a construct
comprising the coding region of Cx26, or its G45E or D50N
mutants, fused or not to Venus (a circularly permuted yellow
fluorescence mutant of the green fluorescent protein) at the
C-terminal end (Beltramello et al., 2005). For some experiments,
HeLa DH or HaCaT cells were transduced with a lentivirus
expressing Cx26, or its G45E or D50N mutants, fused to Venus,
either directly or after application of doxycycline.
Patch Clamp Electrical Measurements
Glass coverslips with adherent connexin-expressing HeLa DH
or HaCaT cells were continuously superfused at 2ml/min at
20–23◦C with an extracellular solution (EXP) containing (in
mM): 140 NaCl, 5 KCl, 10 HEPES, 2 sodium pyruvate, 4
tetraethylammonium chloride (TEA-Cl), 4 CsCl, 5 glucose, and
a reduced (0.2mM) Ca2+ concentration (pH 7.4, 323 mOsm).
Cells expressing Cx26–Venus were selected for patch clamp
recordings by visual inspection using fluorescence microscopy,
whereas cells expressing untagged Cx26 were selected based on
their ability to uptake Lucifer Yellow (CH dilithium salt, Sigma-
Aldrich, Cat. No. L0259) (DeVries and Schwartz, 1992; Saez and
Leybaert, 2014) after 5min of incubation in Ca2+-free (0mM)
EXP containing 1mM of the dye.
Patch pipettes were filled with an intracellular solution
containing (in mM): 115 KAsp, 10 NaCl, 10 KCl, 1 MgCl2, 10
HEPES, 1 CaCl2, and 5 BAPTA tetrapotassium salt (pH 7.2, 311
mOsm) and filtered through 0.22-mm pores (Millipore). Filled
pipettes had resistances of 4–6 M when immersed in EXP.
Hemichannel currents were assayed in EXP under whole cell
patch clamp recording conditions.
The antibody was dissolved in EXP and delivered through
a glass micropipette pulled to a 8µm diameter tip from
B150F glass (World Precision Instruments, Sarasota, USA).
During antibody delivery, the superfusion was stopped. To block
connexin hemichannels, CaCl2 was added at the indicated final
concentrations to EXP, whereas ZnCl2 was added at 100µMfinal
concentration.
ATP Release Assay
HaCaT cells were transduced with a doxyxycline-inducible
lentivirus expressing Cx26 and plated at a density of 1.5 × 103
cells/well in 96-well plates 24 h before the experiment. Cx26
expression was induced by doxycycline addition to the culture
medium 8 h before the measurement of ATP release. Complete
DMEM was removed and cells were washed once with serum-
free DMEM. Plates were then incubated for 30min at 37◦C and
5% CO2. In order to test the ability of the antibody to inhibit ATP
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release through Cx26 hemichannels, abEC1.1 was subsequently
added to the wells to a final concentration of 400 nM, and
cells were incubated in the above-mentioned conditions for an
additional 30min. Immediately before starting the ATP release-
stimulation protocol, cells were washed once with a solution
(NCS) containing a normal (1.8mM) Ca2+ concentration and
(in mM): 137 NaCl, 5.36 KCl, 0.81 MgSO4, 0.44 KH2PO4, 0.18
Na2HPO4, 25 HEPES, and 5.55 Glucose (pH7.3). Cells were
then washed a second time either with the same NCS or with
a solution (ZCS) containing 0 mM Ca2+ concentration and
(in mM): 137 NaCl, 5.36 KCl, 0.44 KH2PO4, 0.18 Na2HPO4,
0.1 EGTA, 25 HEPES, and 5.55 Glucose (pH7.3). To stimulate
the release of ATP through Cx26 hemichannels, cells were
incubated in NCS, ZCS, or ZCS supplemented with abEC1.1
(400 nM) for 10min at 37◦C. The amount of ATP released
in these conditions was measured with a bioluminescent ATP
assay kit (Molecular Probes-A22066) and bioluminescence was
measured by a luminometer (Perkin Elmer Victor Light 1420).
For each experiment, ATP standard curves were generated using
serially-diluted concentrations of ATP and were used to convert
measurements of luminescence signals into ATP concentrations.
Lactate Dehydrogenase (LDH) Release
Assay
LDH release was estimated by measuring optical absorbance (A)
at 490 nm, using a Cytotoxicity LDH Assay Kit-WST (Dojindo
Molecular Technologies, Cat. No. CK12) according to the
manufacturer’s instruction. Briefly, HaCaT cells were seeded in
96-well plates at 8,000 cells per well density and cultured in
100µl DMEMmedium (HyClone, Cat. No. SH30022.01) without
sodium pyruvate and penicillin/streptomycin antibiotics, and
supplemented with 5% FBS (Gibco, Cat. No. 10099141). For each
sample, A was measured by a PerkinElmer Enspire plate reader.
Untransfected cells incubated in normal medium were used as
minimum absorbance (Amin) controls, whereas untransfected
cells exposed to 1% Triton X-100 for 30min before testing
were used as maximum absorbance (Amax) controls. Percent
LDH release (R) was estimated by substituting A-values into the
following formula:
R =
A− Amin
Amax − Amin
× 100
and averaging the results over homogenous sets of eight wells.
Cochlear Organotypic Cultures
Ethics Statement
All experiments involving the use of animals (mice) were
performed in accordance with a protocol approved by the Italian
Ministry of Health (Prot. n.1276, date 19/01/2016).
Preparation
Cochleae from P5 C57BL6/N mice of both sexes were
quickly dissected in ice-cold Hepes buffered (pH 7.2) HBSS
(ThermoFisher, Cat. No. 14025050), placed onto glass coverslips
coated with Cell-Tak (Biocoat, Cat.No. 354240) and incubated
overnight at 37◦C in DMEM/F12 (ThermoFisher, Cat. No.
11320-074) supplemented with 5% FBS (ThermoFisher, Cat. No.
10270-106) and 100µg/ml ampicillin (Sigma-Aldrich, Cat.N.
A0166).
Ca2+ Imaging and Dye Transfer Assays
Cochlear cultures were incubated for 40min at 37◦C in
DMEM/F12, supplemented with fluo-4 AM (16µM, Thermo
Fisher Scientific, Cat. No.F-14201). The incubation medium
contained also pluronic F-127 (0.1%, w/v), and sulfinpyrazone
(250µM) to prevent dye sequestration and secretion. Samples
were then transferred on the stage of a spinning disk confocal
microscope (DSU, Olympus) and perfused with extracellular
solution for 20min at 1ml/min to allow for de-esterification.
The perfusion medium (EXM) contained (in mM): NaCl 135,
KCl 5.8, CaCl2 1.3, NaH2PO4 0.7, MgCl2 0.9, Hepes-NaOH 10,
d-glucose 6, pyruvate 2, amino acids, and vitamins (pH 7.48, 307
mOsm). The abEC1.1 antibody was diluted in EXM at a final
concentration of 952 nM and applied to the cochlear preparation
for 20min before starting the recording. The antibody was
delivered through a glass micropipette pulled to a 8µm diameter
tip on a vertical two-stage puller (PP-830, Narishige) from
B150F glass (World Precision Instruments, Sarasota, USA).
Experiments were performed at near-physiological temperature
(34–36◦C).
Fluorescence excitation was produced by light emitted by
a 488 nm diode laser (COMPACT-150G-488-SM, World Star
Tech) filtered through a narrow band filter (Semrock, Cat.
No. FF02-482/18-25). Fluo-4 emission was filtered through a
535/43m OD6 bandpass interference filter (Edmund Optics).
Confocal fluorescence images were formed by a water immersion
objective (40x, N.A. 0.8, LumPlanFL, Olympus) and projected
on a scientific-grade camera (PCO.Edge, PCO AG) controlled
by software developed in the laboratory. Images were acquired
at one frame per second with a typical exposure time of 100ms,
stored on disk and processed off-line using the Matlab 7.0
software package (The MathWorks Inc.). Ca2+ signals were
quantified pixel-by-pixel as relative changes of fluorescence
emission intensity (1F/F0), where F0 is fluorescence at the
beginning of the recording, F is fluorescence at time t and
1 F = F −F0.
For dye transfer assays, patch clamp glass micropipettes
were filled with Lucifer Yellow, which is broadly used also
as gap junction channel permeability probe (Hernandez et al.,
2007), dissolved at 220µM (final concentration) in a 320 mOsm
intracellular solution containing (in mM): KCl 134, NaCl 4,
MgCl2 1, HEPES 20, EGTA 10 (adjusted to pH 7.3 with
KOH), and filtered through 0.22µm pores (Millipore). Pipette
resistances were 3–4 MOhm when immersed in the bath. One
cell (donor) was patch clamped and maintained in the cell-attach
configuration for a few seconds to establish a baseline. The patch
of membrane under the pipette sealed to the donor cell was
subsequently ruptured, allowing Lucifer Yellow to fill the cell,
while leaving the seal intact (whole cell recording conditions).
The cell was held at its zero current level using the current
clamp configuration of the patch clamp amplifier (Axopatch
200B, Molecular devices). Fluorescence images were acquired at
one frame per second with a typical exposure time of 100ms,
and displayed as (F – Fbck)/(Fmax – Fbck), where Fmax is the
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asymptotic maximal value reached in the injected cell and Fbck
is autofluorescence.
Selection of Cx26 Antibodies from
Combinatorial Antibody Phage Libraries
A peptide corresponding to residues 41–56 of Cx26
(KEVWGDEQADFVCNTL = pepEC1.1) was synthesized
and labeled with biotin at the N-terminus (Chinese
Peptide Company, Hangzhou Economic and Technological
Development Zone, China).
Streptavidin-coated magnetic beads (Pierce, Cat. No. 88817)
were mixed in Tween phosphate buffer (PBST) with biotinilated
pepEC1.1 and screened against a scFv combinatorial library
expressed in phage (Zhang et al., 2012). For the phage panning
process (Barbas et al., 2004; Lee et al., 2007), specific clones
were enriched by binding to immobilized pepEC1.1, followed by
elution with Glycine-HCl (pH 2.2) and repropagation of phage
in XL1-Blue cells. After four rounds of panning, 150 colonies
were picked and analyzed by phage ELISA (see below). Positive
colonies were sequenced and analyzed using the international
ImMunoGeneTics information system R© (Lefranc et al., 2015).
Complementarity determining regions 3 (CDR3s) were aligned
with Clustal X (Larkin et al., 2007) and a phylogenetic tree was
constructed using CLC Genomics Workbench 8.0 (CLCbio). The
genes encoding the scFv candidates, identified by analysis of the
phylogenetic tree, were cloned into a modified pFUSE expression
vector (Invivogen, Cat. No. pfuse-hg1fc2) to obtain scFv-Fc
fusion proteins. 293-F cells were transfected with the scFv-Fc
vectors and the expressed fusion proteins were purified using
HiTrap Protein AHP columns (GEHealthcare, Cat. No.17-0403-
03) with ÄKTApurifier 100 (GE Healthcare). After purification,
the buffer was exchanged to PBS (pH 7.4). The purified scFv-
Fc proteins were kept either at 4◦C, for short-term storage, or at
−80◦C for longer-term conservation.
Western Blot Analyses
The Cx26 coding sequence fused with 10∗His and flag tag was
cloned into a pFastBac1 baculovirus transfer vector and expressed
using the Bac-to-Bac R© Baculovirus Expression System (Life
Technologies, Cat. No. 10359-016, 10360-014, 10584-027, 10712-
024). The baculovirus infected Sf9 cells were cultivated in an ESF
921 insect cell culture medium (Expression Systems, Cat. No. 96-
001-01) at 27◦C for 48 h. The recombinant Cx26 protein was then
purified using a modified protocol described previously (Dupont
et al., 1991; Stauffer et al., 1991).
Alternatively, Hela DH cells transfectants expressing Cx26-
Venus were used to isolate total cellular protein. Around 0.1µg
of protein supernatant was separated in a denaturating 10%
polyacrylamide gel and transferred to a nitrocellulose membrane
by electroblotting.
After blocking with 5% milk powder in washing buffer (TBST,
composed of 10mM Tris-HCl, 150mM NaCl, 0.1% Tween-20,
pH 7.5) for 1 h at room temperature, the nitrocellulosemembrane
was incubated overnight at 4◦C with scFv-Fc fusion proteins
(1mg/ml, dilution factor 1:100). Membranes were washed three
times with TBST and after 1 h they were incubated with goat
anti-human horseradish peroxidase (HRP)-conjugated antibody
(dilution factor 1:2,000; Sigma, Cat. No.A0170), which recognizes
the Fc domain of the scFv-Fc fusion proteins. Finally, membranes
were incubated with SuperSignal West Picochemiluminescence
substrate (Pierce, Cat. No. 34087), which reacts with HRP, and
examined using Bio-Rad ChemiDoc MP (Biorad).
ELISA and Phage Elisa
Ninety-six-well ELISA plates (Corning Costar, Cat. No. 3690)
were filled with 25µl per well of a solution containing avidin
(1µg/well; Pierce, Cat. No. 21121) dissolved in CBS buffer (pH
9.0). Plates were incubated at 4◦C overnight or 37◦C for 1 h. After
washing with PBST buffer (0.05% TWEEN20 in PBS), 25µl of
a pepEC1.1 solution (0.05µg/well, diluted in PBS) was added
to each well and incubated for 1 h at 37◦C. Wells were washed
twice and blocked with 150µl per well of M-PBST (5% milk
in PBST) and incubated for 1 h at 37◦C. After discarding the
blocking solution, 25µl of abEC1.1 solution (1mg/ml, diluted in
M-PBST buffer, dilution factor 1:100) were added and incubated
for 1 h at 37◦C, then washed eight times. Each well then received
50µl of a solution containing goat anti-Human horseradish
peroxidase-conjugated antibody (Sigma, Cat. No. A0170-1ml)
diluted in M-PBST buffer (dilution factor 1:5,000). Plates were
incubated for 1 h at 37◦C and then washed eight times. Finally,
50µl of substrate ABTS solution (Roche, Cat. No. 11684302001)
were added to each well and incubated for 20min at room
temperature. OD was read out at 405 nm on a PerkinElmer
Enspire plate reader.
Relative affinity and specificity of scFv-phages and soluble
scFvs was assessed against the pepEC1.1 antigen. To this end,
10µg/ml of pepEC1.1 were used to coat a microtiter plate
at 4◦C overnight. Any remaining binding sites were blocked
with Blotto (5% w/v of Bovine Serum Albumin in PBST;
bovine serum albumin was purchased from Thermo Fisher, Cat.
No. 23210). Approximately 25µl per well of scFv-phage or
soluble scFv supernatant from overnight cell cultures was added
and incubated for 1 h at 37◦C. For scFv-phage ELISA (Zhang
et al., 2012), after washing, 25µl of anti-M13mAb horseradish
peroxidase (HRP) conjugate (GE Healthcare, Cat. No. 27-9421-
01) diluted 1:1000 in Blotto was added for 30min at 37◦C. For
ELISA using soluble scFv, anti-Human horseradish peroxidase
conjugate (Sigma, Cat. No. A0170-1ml) in Blotto was added and
incubated for 30min at 37◦C. Detection was accomplished by
adding 50µl of ABTS solution (Roche, Cat. No. 11684302001)
and absorbance was measured at 405 nm.
Antibody Crystallization, Diffraction Data
Collection, Structure Determination, and
Refinement
Crystallization was carried out using the hanging drop vapor
diffusionmethod. Crystals of the scFv domain of abEC1.1 grew in
the drop consisting of 0.2µL of the protein solution (8 mg/mL)
and 0.2µL of the reservoir solution (0.1M HEPES, pH7.5, 3M
NaCl). Crystals were cryoprotected using the reservoir solution
supplemented with 20% v/v glycerol and then flash cooled
into the liquid nitrogen. Diffraction data were collected at the
BL18U beam line of Shanghai Synchrotron Radiation Facility
and processed with the HKL-3000 suite (Minor et al., 2006). The
structure of the scFv domain of abEC1.1 was solved with the
MR method using the programs Phaser (McCoy, 2007). The Fv
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fragment of a human antibody structure (PDB ID 2GHW) was
used as the search model. Structure refinement was carried out
using Refmac5 (Murshudov et al., 2011) and model building was
facilitated with the program Coot (Emsley and Cowtan, 2004).
Molecular Modeling and Dynamics
The atomistic model of VH and VL (without linker) derived from
the crystal structure was docked to the extracellular domain of a
published model of Cx26 hemichannel embedded in the plasma
membrane (Zonta et al., 2012) using the ClusPro 2.0 server
(Comeau et al., 2004) in the antibody docking mode (Brenke
et al., 2012). Among the 50 docking configuration generated
by the software, we selected the only one in which the three
CDRs of VH faced the EC1 loop of Cx26, and we tested its
stability by performing a 70 ns molecular dynamics simulation
using the Gromacs 4 package (Pronk et al., 2013) and the
CHARMM 36 force field (Best et al., 2012). After molecular
dynamics thermalization, we obtained a stable configuration in
which VH and VL interacted with three adjacent protomers of the
Cx26 hemichannel. Therefore, we added a second symmetrically
docked pair of VH and VL and obtained a new configuration in
which the pore lumen was completely covered.
The atomistic model system, containing the Cx26
hemichannel inserted in a phospholipid bilayer and the pair
of docked antibodies, underwent a short energy minimization
in vacuum, and was subsequently solvated with full atom
TIP3P water, containing Cl− and K+ ions at a concentration of
∼0.15M in order to mimic a physiological ionic strength. After
solvation, the total number of atoms was around 253,000. We
then performed an equilibrium molecular dynamics simulation
under periodic boundary conditions at constant pressure for an
additional 200 ns.
Temperature T was kept fixed at 300 K in all simulations, and,
where stated, the pressure P was fixed at 1 atm using Berendsen
thermostat and barostat (Berendsen et al., 1984). Fast smooth
Particle-Mesh Ewald summation (Darden et al., 1993) was used
for long-range electrostatic interactions, with a cut off of 1.0 nm
for the direct interactions.
RESULTS
Antibody Selection
Based on the crystal structure of Cx26 gap junction channels
(Maeda et al., 2009) and a related molecular dynamics model
of the Cx26 hemichannel (Zonta et al., 2012), we synthesized
a bait peptide, which we named pepEC1.1, corresponding to
residues 41–56 in the EC1 domain of Cx26. We investigated
the conformation of pepEC1.1 in solution by circular dichroism
(CD) and nuclear magnetic resonance (NMR) spectroscopy, and
determined that the peptide did not fold in solution, therefore
we screened the scFv phage library (Zhang et al., 2012) against
pepEC1.1.
After two rounds of panning (see section Materials and
Methods), an increased enzyme-linked immunosorbent assay
(ELISA) signal was observed for the pepEC1.1 group compared to
the control group (bovine serum albumin, BSA); the scFvs which
specifically bound pepEC1.1 were enriched after four rounds of
panning (Figure 1A). Seven hundred phage-infected clones were
picked randomly from the third and fourth round of panning
and tested for their ability to bind pepEC1.1 using phage ELISA.
One hundred and fifty phage clones were selected from the
original 700 clones as positive binders (pepEC1.1/control >2)
(Figure 1B). Positive colonies were sequenced, complementarity-
determining regions 3 (CDR3) were aligned and a phylogenetic
tree was constructed (Figure 1B, inset). Based on the analysis of
the phylogenetic tree, different scFv sequences were converted
to the scFv-Fc format, in which the scFv domain is fused in
one polypeptide chain to the hinge and fragment constant (Fc)
domain of human immunoglobulin G1 (IgG1) (Bujak et al.,
2014). The binding affinity of the scFv-Fc recombinant antibodies
for pepEC1.1 was quantified by ELISA, and the most promising
scFv-Fc candidate (Figure 1C) was named abEC1.1.
FIGURE 1 | Selection of antibodies in phage. (A) Optical density readout from
a plate reader vs. panning round for a negative control antigen (BSA, red) and
the pepEC1.1 bait peptide (blue); only pepEC1.1 shows a signal increase after
two rounds of enrichment. (B) Phage ELISA results showing optical density
readout from the plate reader vs. colony number, ranked by increasing signal
intensity. Positive clones (pepEC1.1/BSA ratio > 2) were sequenced and a
phylogenetic tree based on the heavy-chain CDR3 sequences was
constructed (inset; clones are labeled by the protocol used to obtain them and
the clone number of each protocol). (C,D) After purification, the binding
specificity of the candidate antibody, abEC1.1, was tested by ELISA, against
pepEC1.1 (C), and by western blot, against Cx26 proteins (D), fused with a
10*His and flag tag (29.4 kDa) and purified from a Sf9 expression system (left),
or from proteins obtained from HeLa DH transfectants expressing the 52 kDa
chimeric protein Cx26-Venus (right). The negative control peptide in (C)
corresponds to residues 172 to 184 of Cx26 (sequence:
AWPCPNTVDCFVSR), which form part of EC2.
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In western blot analyses of Cx26 protein fused with a 10∗His
and flag tag (29.4 kDa) and purified from a Sf9 expression
system (see section Materials and Methods), abEC1.1 showed a
band between 25 and 32 kDa (Figure 1D, left). Likewise, using
total cellular proteins obtained from HeLa DH cells (a clone
virtually devoid of native connexins) transfected with Cx26-
Venus (Beltramello et al., 2005), abEC1.1 showed a band between
46 and 58 kDa (Figure 1D, right), in agreement with the expected
molecular weight of Cx26-Venus (52 kDa).
The abEC1.1 Antibody Inhibits Connexin
Hemichannel Currents
To determine whether abEC1.1 binding to Cx26 interferes with
hemichannel function, we performed patch clamp experiments
on HeLa DH cells expressing Cx26-Venus. In low extracellular
Ca2+ conditions (0.2mM), which favor the opening of connexin
hemichannels (Saez et al., 2005; Fasciani et al., 2013; Saez
and Leybaert, 2014; Bennett et al., 2016), the dose-inhibition
response curve of membrane conductance, normalized to pre-
antibody application levels, vs. abEC1.1 concentration yielded
a half maximal inhibitory concentration (IC50) of ∼40 nM
(Figures 2A,B). The inhibitory effect of abEC1.1 on Cx26
hemichannels was incomplete, leaving a residual conductance of
17.5% ± 4.1% (n = 4) at saturating concentrations (952 nM).
Similar results were obtained in HeLa DH cells expressing Cx26
not fused to Venus (residual conductance at 952 nM: 15.9± 3.4%,
n = 4, P = 0.8, ANOVA).
The currents affected by the antibody were inhibited by
extracellular Ca2+, in a dose-dependent manner, and abrogated
by Zn2+ (100µM; Figure 2C), a non-specific Cx26 hemichannel
blocker (Sanchez et al., 2014; Levit et al., 2015).
FIGURE 2 | The abEC1.1 antibody inhibits Cx26 hemichannel currents with IC50 of ∼40 nM. (A) Membrane conductance measured with the step protocol in (B) and
normalized to pre-antibody application levels, vs. abEC1.1 concentration. Each data point is the mean ± s.e.m. for n = 5 cells; the solid line is a least-square fit with a
modified Hill equation y = α [1+(x/γ)n]−1 + β, where x is antibody concentration (in nM), α = 0.832, β = (1 −α) = 0.168, γ = 36.926 nM, and n = 2. (B)
Representative whole cell currents elicited by shown voltage commands (top, black trace) in HeLa DH cells transiently transfected with Cx26-Venus; shown are mean
(thick traces) ± s.e.m. (thin traces) for n = 5 cells before (blue traces, control) and after application of abEC1.1 at 952 nM for 15min (green traces) in 0.2mM Ca2+.
Data were normalized to the mean value of the control response during the application of the +40mV depolarization step. Top insets show normalized current
immediately after the voltage commands to +40mV (outward current) and −60mV (tail current). Bottom inset shows time constant of a single exponential fit to the tail
current decay over time. Asterisks indicate significance level between control condition and antibody application (**P < 0.01; ***P < 0.001, paired t-test). (C) Whole
cell currents were reduced by extracellular Ca2+ in a concentration-dependent fashion (magenta and black traces) and were abrogated by adding 0.1mM Zn2+ (gray
trace) to the extracellular medium containing 0.2mM Ca2+.
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abEC1.1 Inhibits Connexin Hemichannels
but Not Gap Junction Channels in Mouse
Organotypic Cochlear Cultures
In the mammalian cochlea, ATP is released under various
conditions (Housley et al., 2009) from the organ of Corti
(Wangemann, 1996; Zhao et al., 2005) and the lateral wall
(Munoz et al., 2001; Chen et al., 2015). Here, we used organotypic
cochlear cultures from P5 mice (Beltramello et al., 2005). In
this model system, which is known to express endogenous
Cx26 (Ortolano et al., 2008), the release of ATP from connexin
FIGURE 3 | The abEC1.1 antibody inhibits connexin hemichannels but not gap junction channels in the mouse postnatal cochlea. (A) False-color images of fluo-4
fluorescence change (1F/F0), encoded as shown by the color scale-bar, obtained as maximal projection rendering of all frames recorded in an apical turn culture from
the greater epithelial ridge of a P5 mouse imaged for 5min at one frame per second in the presence of the abEC1.1 antibody (left) and after antibody washout with
normal extracellular solution (right). The experiment was replicated two times. (B) Fluo-4 traces generated from the experiment in (A) as pixel averages from 10
non-sensory cells of the greater epithelial ridge in the presence of the antibody (952 nM, top) and after washout (bottom); (C) Analysis of data in (B), showing
frequency histograms of spontaneous cytosolic Ca2+ transients (events) in the presence of the antibody (952 nM, left) and after washout (right); in each graph, the
solid black line (right ordinates) is the time integral of the corresponding frequency histogram and, as such, it tracks the mean number of events in the cell population
from the onset of the recording. (D) Box plots showing distribution of areas invaded by intercellular Ca2+ waves in the presence of the antibody (952 nM, left) and after
washout (right); invaded areas were significantly reduced in the presence of the antibody (***P < 0.001, two-tailed Mann-Whitney U-test). Data in (D) were obtained
from two cochlear cultures, n = 117 Ca2+ waves in the washout and 74 in the antibody condition. Box plot conventions: the upper and lower whisker of the plot
extend to the maximum value below Q3+1.5* IQR and the minimum value above Q1–1.5*IQR, respectively, where Q1 is the first quartile, Q3 is the third quartile, and
IQR = Q3-Q1; outliers are not shown. (E) Dye transfer assays in the absence of abEC1.1 (Control, left) and after 4 h of incubation with abEC1.1 (952 nM, right).
(F) Lucifer yellow fluorescence emission averaged over the cell body of (first order) cells adjacent to the injected cell, and normalized to the maximal fluorescence
emission at t = 300 s; data are mean values (solid traces) ± s.e.m. (dashed lines) for n = 6 cells in each condition; the experiment was replicated three times.
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hemichannels plays a crucial role in intercellular Ca2+ signaling
both in the lesser epithelial ridge (Anselmi et al., 2008; Majumder
et al., 2010; Ceriani et al., 2016) and in the greater epithelial
ridge (Tritsch et al., 2007; Schutz et al., 2010; Rodriguez
et al., 2012; Wang and Bergles, 2015; Johnson et al., 2017).
Incubating cochlear organotypic cultures with abEC1.1 for
15–20min severely but reversibly reduced the frequency of
spontaneous Ca2+ transients in the greater epithelial ridge, as
well as the area of tissue invaded by each event (Figures 3A–D
and Supplementary Video 1).
Numerous studies have reported that connexins have half-
lives of 1.5–3.5 h (Thomas et al., 2005; Esseltine and Laird,
2016), and that antibodies targeted to the extracellular domain
of connexins may interfere with the assembly of gap junction
channels (Riquelme et al., 2013). Therefore, we assayed dye
transfer among non-sensory cells of the lesser epithelial ridge
after incubating cochlear organotypic cultures for 4 h with
abEC1.1 at a saturating concentration (952 nM). The cell-to-cell
spreading of Lucifer Yellow over time was not hampered by the
antibody (Figures 3E,F and Supplementary Video 2), indicating
FIGURE 4 | Immunolabeling of non-sensory cells in cochlear organotypic cultures from P5 C57BL6/N mice. Shown are through-focus confocal sequences (z-stacks)
taken at 0.5µm intervals under the indicated labeling conditions using a laser scanning confocal microscope (Leica, TCS SP5) equipped with a 40X objective (Leica,
HCX pl apo 1.25 0.75 oil). All samples were mounted onto glass slides with a mounting medium (FluorSaveTM Reagent, Merk, Cat. No. 345789). Scale bars, 25µm.
(A) Cultures were fixed in 4% paraformaldehyde (PFA) for 20min at room temperature, permeabilized for 15min with 0.1% v/v TritonX-100 at room temperature and
incubated with CX-1E8, a commercial mouse monoclonal antiCx26 antibody (ThermoFisher, Cat. No. 33-5800). CX-1E8 was visualized with a goat-anti-mouse
Alexa488-conjugated secondary antibody (Thermo Fisher, Cat. No. A-11029). Cells were counter-stained by labeling F-Actin with Alexa Fluor® 568 Phalloidin
(ThermoFisher, Cat. No. A12380), diluted 1:200 in rinse solution, for 1 h at room temperature. (B) To label the plasma membrane, live cultures were counter stained
with Wheat Germ Agglutinin (WGA) Texas Red®-X Conjugate (Thermofisher, Cat. No. W21405) following the manufacture’s instruction. Cultures where then fixed, but
not permeabilized, in 4% paraformaldehyde (PFA) for 20min at room temperature, washed times times in PBS, then rinsed in PBS containing 2% BSA and incubated
overnight at 4◦C with abEC1.1 (2µg/ml) dissolved in rinse solution (1% BSA in PBS), and finally washed three times in PBS (5min each time). abEC1.1 was visualized
with a Fluorescein AffiniPure Donkey Anti-Human IgG (H+L) secondary antibody (Jackson ImmunoResearch, Cat. No. 709-545-149), diluted 1:100 in rinse solution,
and applied for 1 h at room temperature. (C) Cultures were incubated with abEC1.1 pre-empted by overnight incubation with cognate peptide (pepEC1.1, dissolved in
DMSO) in a 1:10 (w/w) proportion and processed as in (B).
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that abEC1.1 does not affect dye transfer through gap junction
channels in this tissue.
The presence of gap junctions in these dye coupled cells
was confirmed by immunolabeling detergent-permeabilized
cochlear organotypic cultures with a commercial monoclonal
anti-Cx26 antibody (Figure 4A). In non-permeabilized cultures,
we detected abEC1.1 immunoreactivity in the apical plasma
membrane (Figure 4B), consistent with the capacity of abEC1.1
to recognize surface-exposed Cx26 but not gap junction channels.
These results are similar to those previously obtained with
CELAb polyclonal antibodies (Clair et al., 2008) in organotypic
cochlear cultures (Anselmi et al., 2008; Majumder et al., 2010).
abEC1.1 immunoreactivity was eliminated by pre-incubating the
antibody with its cognate peptide, pepEC1.1 (Figure 4C).
To examine potential cytotoxic effects of the antibody,
cochlear organotypic cultures were incubated overnight in
serum-free culture medium supplemented with abEC1.1
(952 nM). A subsequent live/dead fluorescence assay
(Figure 5) showed an overwhelming proportion of viable
cells, indistinguishable from controls not exposed to the
antibody. In contrast, cell viability in these organotypic
cultures was compromised after just 1 h of incubation
with mefluoquine, a small-molecule analog of the anti-
malarian drug quinine, which requires a concentration of
100µM (used in these assays) to inhibit Cx26 hemichannels
by ∼70% (Levit et al., 2015), i.e., less than the maximal
inhibition imparted by abEC1.1 at (non-toxic) concentrations
<1µM.
FIGURE 5 | The abEC1.1 antibody is not toxic to cells of the mouse postnatal cochlea. Green, calcein AM; red, Dextran-Texas Red 70,000mW. GER, greater
epithelial ridge; IHC, inner hair cells (single row); OHCs, outer hair cells (three rows); LER, lesser epithelial ridge. Scale bars: 20µm. For these experiments, cochlear
organotypic cultures, obtained from P5 C57BL6/N mouse pups, were incubated overnight for 16 h at 37◦C and 5% CO2 in DMEM/F12 (without FBS) supplemented
with abEC1.1 (952 nM). The following day, cultures were incubated for 5min at room temperature in DMEM/F12, supplemented with Calcein AM (5µM, ThermoFisher,
Cat. No. C1430). The incubation medium contained also 0.1% w/v pluronic F-127 and sulfinpyrazone (250µM) to prevent dye sequestration and secretion. Cultures
were then transferred to the stage of a laser scanning multiphoton confocal microscope (Bergamo 2, Thorlabs) and incubated in extracellular solution (EXM)
supplemented with Dextran-Texas Red 70,000mW (1.78µM, ThermoFisher, Cat. No. D1830) for 30min. Calcein fluorescence was excited at λ = 780 nm and
detected with a Semrock 525/40 nm band bandpass filter (FF02-525/40-25). Texas Red fluorescence was excited at λ = 1100 nm and detected with a Semrock
625/90 nm BrightLine® CARS bandpass emission filter (FF01-625/90-25). In live cells, the non-fluorescent calcein AM is converted to a green-fluorescent dye after
acetoxymethyl ester hydrolisys by intracellular estares. Labeled dextrans are membrane-impermeable polysaccharides that are excluded from the cytoplasm of live
cells, but bind extracellular structures or intracellular components of cells with compromised plasma membrane.
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FIGURE 6 | abEC1.1 inhibits keratinocytes hemichannel currents and ATP release, and is not toxic to cells. (A) Black traces at the top represent voltage commands
applied under patch clamp conditions to elicit whole cell currents in wild type HaCaT cells (blue traces, middle) and in cells over-expressing Cx26 following lentiviral
transduction (HaCaT-Cx26, blue trace, bottom); the experiment was replicated three times in each condition. (B) Whole cell currents elicited by shown voltage
commands (top, black trace); shown are mean (thick traces) ± s.e.m. (thin traces) for n = 3 HaCat-Cx26 cells before (blue traces, control) and after application of
abEC1.1 at 952 nM for 15min (green traces). Data were normalized to the mean value of the control response during the application of the +40mV depolarization
step. Top insets show normalized current immediately after the voltage commands to +40mV (outward current) and −60mV (tail current). Bottom inset shows time
constant of a single exponential fit to the tail current decay over time. Asterisks indicate significance level between control condition and antibody application
(*P < 0.05; **P < 0.01, paired t-test). (C) LDH release assay (***P < 0.001, ANOVA); this experiment was replicated two times. Error bars represent s.e.m. (D) ATP
release assay (**P < 0.01, ANOVA); this experiment was replicated two times. NCS, normal Ca2+ solution (1.8mM Ca2+); ZCS, nominally Ca2+-free solution (0mM
Ca2+ and no added EGTA). Data are mean values ± s.e.m. for n = 4 wells in each condition.
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abEC1.1 Inhibits Connexin Hemichannels
in Cultured Human Keratinocytes
To explore further the potential applications of this antibody,
we performed patch clamp experiments in a keratinocyte cell
line from adult human skin (HaCaT cells) which maintain full
epidermal differentiation capacity (Boukamp et al., 1988). Wild
type HaCaT cells exhibited negligible whole cell currents (<200
pA) in response to voltage commands in 0.2mM extracellular
Ca2+, whereas currents >2 nA were measured in HaCaT-Cx26,
i.e., HaCaT cells in which stable expression of Cx26 was induced
by lentiviral infection (Figure 6A). abEC1.1 (952 nM) inhibited
these currents by > 80% (Figure 6B), consistent with the results
obtained in HeLa DH transfectants.
To test antibody cytotoxicity in keratinocytes, we used a
LDH release assay. LDH is a stable enzyme, present in all
types of cells, which is normally retained in the cytoplasm,
but is released into the medium in the presence of cytotoxic
agents (see section Materials and Methods). abEC1.1, applied
overnight at saturating concentrations (115, 400, and 952 nM)
reduced slightly LDH release in both wild type and HaCaT-
Cx26 cells, whereas incubation with mefluoquine (100µM) for
1 h increased LDH release by >9-fold compared to control
conditions (Figure 6C). These results indicate that abEC1.1 can
be safely applied to cultured keratinocytes, whereas mefluoquine
is toxic. In accord with the inhibition of ATP-dependent
spontaneous Ca2+ signaling activity in cochlear organotypic
FIGURE 7 | abEC1.1 inhibits dye uptake in keratinocytes. HaCaT cells, either wild type (WT, A) or stably expressing Cx26-Venus (B–D) were bathed in extracellular
medium containing: (A, B) 0mM Ca2+; (C) 0mM Ca2++ 952 nM abEC1.1; (D) 2mM Ca2+. Each experiment was replicated three times. Column (1) displays the
cells before incubation with Lucifer Yellow (LY); column (2) shows the same field of view after the 5min incubation with LY (1mM, 5min); column (3) is the difference
between the two (2-1); scale bar, 50µm. Box plots represent the distributions of fluorescence values measured in 50 different cells before (1) and after (2) incubation
with LY (***p < 0.001, Mann-Whitney U test).
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FIGURE 8 | The abEC1.1 antibody reduces the activity of hyperative Cx26
hemichannels in keratinocytes. (A) Model of a Cx26 hemichannel embedded
in a phospholipid membrane; two of the amino acids implicated in KID/HID
syndrome (G45, D50) are shown in yellow. (B) Representative whole cell
currents elicited by shown voltage commands (black traces) applied to HaCaT
(Continued)
FIGURE 8 | Continued
cells expressing Cx26 mutants G45E or D50N. Data are mean values (thick
traces) ± s.e.m (thin traces) for n = 3 cells in each set. Top insets show
normalized current immediately after the voltage commands to +40mV
(outward current) and −60mV (tail current). Bottom inset shows time constant
for a single exponential fit to the tail current decay over time. Asterisks indicate
significance level between control condition and antibody application
(*P < 0.05; **P < 0.01, paired t-test).
cultures, abEC1.1 (400 nm) reduced also the release of ATP
from cultured keratinocytes exposed to a Ca2+-free medium for
10min (Figure 6D; see sectionMaterials andMethods for further
details).
Cellular uptake of fluorescent tracers allows real time
measurements of membrane permeability properties via
hemichannels (Saez and Leybaert, 2014). Lucifer Yellow uptake
was undetectable in wild type HaCaT cells incubated for 5min in
nominally Ca2+-free (0mM) extracellular medium (Figure 7A),
but was prominent in HaCaT–Cx26 cells (Figure 7B). Dye
uptake was inhibited either by pre-incubating HaCaT–Cx26 cells
with abEC1.1 (952 nM) for 20min in 0mM Ca2+ (Figure 7C),
or by maintaining the cells in 2mM Ca2+ (Figure 7D). These
results indicate that abEC1.1 abrogates dye uptake through
connexin hemichannels.
The D50N mutation of Cx26 causes the most common
form of KID/HID, whereas the G45E mutation has been linked
to lethal forms of the syndrome (Martin and van Steensel,
2015). We induced transient expression of G45E or D50N
mutant hemichannels in HaCaT cells. As expected, most cells
displayed visible sign of stress within few hours post transfection.
Nonetheless, we succeeded to perform patch clamp experiments
on some of them. In 0.2mM extracellular Ca2+, Cx26 G45E
hemichannel currents were similar to wild type Cx26 currents,
whereas Cx26 D50N exhibited faster tail current kinetics, as
previously reported for hemichannels expressed in Xenopous
oocytes (Sanchez et al., 2013). Importantly, both G45E and
D50N, continued to show inhibition by abEC1.1 (Figure 8).
Identification of Residues that are Critical
for abEC1.1 Binding to Cx26 Hemichannels
Considering abEC1.1 a promising candidate, we solved the
crystal structures of its scFv domain (Figure 9A; the statistics
of data collection and structure refinement are summarized in
Table 1). Five of the seven amino acids that link VH to VL were
not solved, however the structure is compatible with that of a
diabody (Holliger et al., 1993; Perisic et al., 1994). Therefore,
abEC1.1 is expected to assemble as diabody-Fc, i.e a dimer of two
scFv-Fc polypetides where VH and VL from one scFv, pair with
the complementary domains of a second scFv (Wu et al., 2001).
To gain insight into the interaction of the antibody with its
target, we combined the crystal structure of the scFv domain
(Figure 9A) with an atomistic model of the Cx26 hemichannel
(Zonta et al., 2012). In agreement with the results of Figure 2A,
we simulated the docking two scFv diabodies to the extracellular
domain of the hemichannel and used molecular dynamics to
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FIGURE 9 | Critical determinants of abEC1.1 antibody binding to Cx26 hemichannels. (A) Structure of the scFv domain of abEC1.1, determined by X-ray
crystallography. Left: two VL-VH pairs are shown in cartoon representation; one polypeptide is drawn in purple with complementarity-determining regions (CDRs) in
cyan, the other in orange with CDRs in green. Right: alpha-carbon backbone; chain VL (1)-VH(1) is drawn in thick lines and VL (2)-VH(2) in thin lines; the red dashed line
between G121 and S127 (1.39 nm) represents 5 of the 7 amino acids that were not solved between VL (1) and VH (1) (the corresponding line between VL (2) and VH (2)
is not shown). (B) Residues critical for binding singled out in silico: green, antibody (ab) heavy chain (VH ); red, antibody light chain (VL ); two protomers of the Cx26
hemichannel (CxA, CxB), which interact with VH, are colored in cyan and pink, while the other protomers are colored in light gray; amino acids mentioned in the main
text (Y34, H55, W104 for the antibody; N54, T55, L56 for the two connexins) are shown in licorice representation.
thermalize the interacting systems. In this computational model,
three CDR residues of the abEC1.1VH (Y34 in CDR1, H55 in
CDR2, and W104 in CDR3) interacted with N56, T57, and L58
residues of Cx26 at the apex of the EC1 loop (Figure 9B and
Supplementary Video 3).
To test this prediction, we mutated one by one the
three putatively critical amino acids of abEC1.1. Patch clamp
assays confirmed a significantly reduced blocking power of
abEC1.1 mutants compared with wild type abEC1.1 (Figure 10).
We performed also computer-simulated electrophysiological
experiments. To speed up these time-consuming simulations, we
removed the VH and VL domains of each bound scFv diabody
that did not interact with the hemichannel (Supplementary Video
4). The starting configuration was stable within the simulated
time window (150 ns) also in the presence of an external electrical
potential. Small monatomic ions escaped through narrow holes
at the interface between connexins and bound antibodies, as
the latter did not create a perfect seal at the extracellular
mouth of the hemichannel. Nevertheless, the bound antibodies
reduced the simulated ionic current passing through the pore
to 42 ± 14% of its control value (Figure 11A), in qualitative
agreement with the experimental results (Figures 2A,B). In this
model, the inhibitory effect of the antibodies is associated with a
reduction of the hemichannel pore diameter following antibody
binding to the EC1 epitope described above (Figures 11B,C). In
agreement with these experimental results, molecular dynamics
simulations showed that ATP escapes from the extracellular pore
vestibule of the free hemichannel in few nanoseconds, whereas
bound antibodies impede ATP release to the extracellular milieu
(Supplementary Video 5).
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TABLE 1 | Statistics of data collection and scFv structure refinement.
DIFFRACTION DATA
Wavelength (Å) 1.000
Space group P4212
CELL PARAMETERS
a, b, c (Å) 119.49, 119.49. 94.11
Resolution (Å) 50.00-2.65 (2.70–2.65)
Redundancy 6.6 (4.0)
Completeness (%) 96.1 (92.4)
Average I/σ< I > 10.9 (1.9)
Rmerge (%) 10.1 (36.7)
REFINEMENT
Rwork/Rfree 0.242/0.267
rmsd bond length (Å) 0.007
rmsd bond angle (Å) 1.137
Average B (Å2) 41.46
RAMACHANDRAN PLOT (%)
Favored 98.9
Allowed 1.1
Disallowed 0.0
FIGURE 10 | Effect of wild type abEC1.1, its mutants Y34S, H55A, W104S,
and an isotype control antibody (Iso) on Cx26 hemichannel currents in HeLa
DH transfectants. (A) Shown are mean values (thick traces) ± s.e.m. (thin
traces) for n = 3 cells in each data set. All antibodies were applied by pressure
at 952 nM concentration from a glass micropipette; Zn2+ was delivered
through the perfusion at 0.1mM concentration. (B) Membrane conductance
(mean ± s.e.m.) from data in (A), normalized to pre-antibody application
levels, was tested using the voltage protocol of Figure 2. Asterisks indicate
significance level (***P < 0.001, ANOVA) relative to abEC1.1 effect on Cx26
(from Figure 2). Note that antibody residues mentioned in this article do not
follow the Kabat numbering scheme.
Altogether, these results indicate that abEC1.1 inhibits
connexin hemichannels by binding an epitope at the apex of the
EC1 loop.
DISCUSSION
By screening a phage library, we successfully isolated a human
scFv that binds a peptide derived from the EC1 loop of Cx26,
and converted it into the scFv-Fc format (Bujak et al., 2014). The
FIGURE 11 | Molecular dynamics simulation of antibody effects on Cx26
hemichannels. Results obtained in the presence or absence of two bound
antibodies are represented by green and blue traces, respectively.
(A) Simulated electrophysiology experiments; for these simulations we applied
an external constant electric field Ez = 0.0022V/nm, which corresponds to a
membrane potential of V = EzLz = 40mV, where Lz represent the size of the
simulation box in the z (i.e., the field) direction (Gumbart et al., 2012). The two
traces represent the time course of a function the limit of which, for t
approaching infinity, is the unitary hemichannel current. The limits, estimated
by computing the average of function Q(t)/t over the last 50 ns of the
corresponding molecular dynamic simulation, when the function fluctuated
around a steady plateau level (shown in the graph as horizontal lines) were
(Continued)
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FIGURE 11 | Continued
10.6 ± 1.1 pA (in the absence of antibodies) and 4.4 ± 1.0 pA (in the
presence of the antibodies) (P < 10−4). To reduce the large statistical errors
due to the limited time windows, we computed the current with and without
antibodies as the averages over the last 50 ns of the functions Q(t)/t, that is
after it reaches a plateau. In order reduce the artifacts due to the finite size of
the system (Gumbart et al., 2012) we imposed the same box size in both
simulations. Next, we computed the ratio between these two averages
whereas the error was estimated from the propagation of the standard errors.
(B,C) Radius of the Cx26 hemichannel pore vs. axial pore coordinate (B) or
time at z = −30 Å (C), where the change imparted by the presence of the
bound antibodies is maximal; shown are mean (thick traces) ± s.e.m. (thin
traces) with the corresponding p-values estimated from the last 10 ns of
molecular dynamics simulation. P-values were computed with one-tail t-tests.
latter offers several advantages over the phage display-derived
scFv, including bivalent binding and longer half-life, and may be
used in the clinic for therapeutic application (Beck and Reichert,
2011). However, antibodies selected on the basis of binding to
a recombinant membrane protein or one of its domains may
not bind the same protein when it is in its native context (Lipes
et al., 2008). We provide compelling evidence that connexin
hemichannels are the identified target of abEC1.1, as opposed to
some off-target interaction.
First of all, abEC1.1 inhibited ionic currents through Cx26
hemichannels with IC50 of ∼40 nM. Furthermore, variants of
abEC1.1 carrying single amino acid substitutions in critical VH
CDR positions, predicted to mediate the interaction with the
Asparagine-Threonine-Leucine (N-T-L) amino acid motif at the
apex of the EC1 loop, reduced significantly the ability of abEC1.1
to inhibit Cx26 hemichannel currents in HeLa DH transfectants.
abEC1.1 interfered not only with ionic conductance but also
with the release of ATP, as demonstrated by our experiments with
Cx26-expressing human keratinocyte-derived cells.
In addition, the antibody inhibited ATP-dependent
spontaneous Ca2+ signaling activity (Tritsch et al., 2007;
Schutz et al., 2010; Rodriguez et al., 2012; Wang and Bergles,
2015; Johnson et al., 2017) in the greater epithelial ridge of
cochlear organotypic cultures obtained from P5 mice.
Of note, the results of dye transfer assays in cochlear tissue
suggest that the fence function exerted by tight junctions
(Rodriguez-Boulan andNelson, 1989), which provide a boundary
between the apical and basolateral plasma membrane domains
to maintain cell polarity (Wilcox et al., 2001), was preserved in
the superficial layer of non-sensory cells in these organotypic
cultures.
Our atomistic model suggests that the inhibitory action of
abEC1.1 is mediated by partial occlusion of the extracellular
pore mouth and reduction of the hemichannel diameter.
The difference between the residual current determined
experimentally (18%) and that predicted by the model (42%)
may be due the fact that large permeating molecules, not
included in our ionic current simulations (e.g., ATP), remain
stuck in the antibody-capped hemichannel, further reducing
the residual ionic conductance. Despite these shortcomings, the
model allowed us to identify critical residues in the binding
interface. Thus, we are confident that the in silico analysis we
performed here can aid antibody refinement by intelligent CDR
editing, aimed at improving selectivity and performance, as well
as at identifying new antibodies against different connexins.
Last, but not least, we show that abEC1.1, at sub-micromolar
concentrations, inhibits Cx26 mutant hemichannels (G45E,
D50N) expressed in a human keratinocyte cell line. Thus,
these results are remarkable and promising, in a therapeutic
perspective, as: (i) is abEC1.1 is a human monoclonal antibody,
(ii) the D50N mutation causes the most common form of
KID/HID syndrome, whereas (iii) the G45E mutation has been
linked to lethal forms of the syndrome (Martin and van Steensel,
2015).
Recently, mefluoquine and Zn2+ have been reported to inhibit
these and other mutants of Cx26 with IC50 of 16 and 3µM,
respectively, but both required concentrations of the order of
100µM to eliminate >70% of hemichannel currents (Sanchez
et al., 2014; Levit et al., 2015). Mefluoquine is known to block
voltage-gated L-type calcium channels, Kir6.2 and KvLQT1
potassium channels and pannexin channels, whereas Zn2+, as
most divalent cations, is likely to promote numerous off-target
interactions (Levit et al., 2015). Furthermore, we showed here
that mefluoquine, unlike abEC1.1, is toxic to cultured human
keratinocytes as well as mouse cochlear tissue.
Ex vivo gene therapy (Mavilio et al., 2006; De Luca et al., 2009),
stem cell transplantation (Tolar et al., 2009; Tamai et al., 2011),
and administration of allogeneic fibroblasts (Wong et al., 2008) or
recombinant protein (Remington et al., 2009) have been explored
as potential therapeutic avenues for patients with inherited skin
disorders. However, these approaches meet both technical and
safety problems (Uitto et al., 2012).
Intradermal injection of monoclonal neutralizing antibodies
(FnAbs) against actin-remodeling protein has been reported to
accelerate wound reepithelialization improving the macroscopic
appearance of early scars in porcine models of wound healing
(Jackson et al., 2012). Likewise, topical application of an antibody
cream formulation significantly improved the skin barrier
function and reduced the skin fragility (up to 50%) in a murine
model of epidermolysis bullosa acquisista (Kopecki et al., 2013).
Further studies will clarify whether the antibody we identified
can be used to treat connexin-related skin pathologies in animal
models.
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